Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,002,185 papers from all fields of science
Search
Sign In
Create Free Account
Interferon-alpha
Known as:
IFN-A
, alpha-interferon
, Interferon.alpha
Expand
One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
46 relations
Narrower (23)
Alferon N
DAI protocol
IFNA13 protein, human
IFNA7 protein, human
Expand
Antineoplastic Agents
IFNA1 gene
IFNA17 gene
IFNA2 gene
Expand
Broader (2)
Immunologic Factors
Interferons
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.
R. Motzer
,
Thomas E. Hutson
,
+11 authors
R. Figlin
New England Journal of Medicine
2007
Corpus ID: 9329897
BACKGROUND Since sunitinib malate has shown activity in two uncontrolled studies in patients with metastatic renal-cell carcinoma…
Expand
Review
2006
Review
2006
Cytokines sing the blues: inflammation and the pathogenesis of depression.
C. Raison
,
L. Capuron
,
Andrew H. Miller
Trends in immunology
2006
Corpus ID: 6226469
Highly Cited
2006
Highly Cited
2006
5'-Triphosphate RNA Is the Ligand for RIG-I
V. Hornung
,
J. Ellegast
,
+9 authors
G. Hartmann
Science
2006
Corpus ID: 22436759
The structural basis for the distinction of viral RNA from abundant self RNA in the cytoplasm of virally infected cells is…
Expand
Highly Cited
2004
Highly Cited
2004
Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8
F. Heil
,
H. Hemmi
,
+6 authors
S. Bauer
Science
2004
Corpus ID: 1680581
Double-stranded ribonucleic acid (dsRNA) serves as a danger signal associated with viral infection and leads to stimulation of…
Expand
Review
2004
Review
2004
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
D. Lavanchy
Journal of Viral Hepatitis
2004
Corpus ID: 163757
Summary. Hepatitis B virus (HBV) infection is a serious global health problem, with 2 billion people infected worldwide, and 350…
Expand
Highly Cited
2003
Highly Cited
2003
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.
S. O’Brien
,
F. Guilhot
,
+22 authors
B. Druker
New England Journal of Medicine
2003
Corpus ID: 20464466
BACKGROUND Imatinib, a selective inhibitor of the BCR-ABL tyrosine kinase, produces high response rates in patients with chronic…
Expand
Highly Cited
2001
Highly Cited
2001
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
B. Druker
,
M. Talpaz
,
+8 authors
C. Sawyers
New England Journal of Medicine
2001
Corpus ID: 8399298
BACKGROUND BCR-ABL is a constitutively activated tyrosine kinase that causes chronic myeloid leukemia (CML). Since tyrosine…
Expand
Highly Cited
1998
Highly Cited
1998
Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy.
A. Neumann
,
N. Lam
,
+4 authors
A. Perelson
Science
1998
Corpus ID: 44374720
To better understand the dynamics of hepatitis C virus and the antiviral effect of interferon-alpha-2b (IFN), viral decline in 23…
Expand
Review
1994
Review
1994
Cytokine therapeutics: lessons from interferon alpha.
J. Gutterman
Proceedings of the National Academy of Sciences…
1994
Corpus ID: 2490970
Cytokines are soluble proteins that allow for communication between cells and the external environment. Interferon (IFN) alpha…
Expand
Highly Cited
1986
Highly Cited
1986
Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.
J. Hoofnagle
,
K. Mullen
,
+6 authors
E. Jones
New England Journal of Medicine
1986
Corpus ID: 28678561
We treated 10 patients who had chronic non-A,non-B hepatitis with recombinant human alpha interferon in varying doses (0.5 to 5…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE